Evidence map›Paper›PMID 24649058›Full record

ArticleBiomedical reports2013

Association of genetic polymorphism of HLA-DRB1 antigens with the susceptibility to lepromatous leprosy.

Monica Escamilla-Tilch, Nora Magdalena Torres-Carrillo, Rosalio Ramos Payan, Maribel Aguilar-Medina, Ma Isabel Salazar, Mary Fafutis-Morris, Roberto Arenas-Guzman, Sergio Estrada-Parra, Iris Estrada-Garcia, Julio Granados

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedical reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Monica Escamilla-TilchDepartment of Immunology, National School of Biological Sciences, National Polytechnic Institute, Mexico City 11340, Mexico.
Nora Magdalena Torres-CarrilloDepartment of Basic Science Research, National Institute of Geriatrics, Ministry of Health, Mexico City, 10200, Mexico.
Rosalio Ramos PayanSchool of Chemical and Biological Sciences, Autonomous University of Sinaloa, Culiacan, Sinaloa 80040, Mexico.
Maribel Aguilar-MedinaSchool of Chemical and Biological Sciences, Autonomous University of Sinaloa, Culiacan, Sinaloa 80040, Mexico.
Ma Isabel SalazarDepartment of Immunology, National School of Biological Sciences, National Polytechnic Institute, Mexico City 11340, Mexico.
Mary Fafutis-MorrisCenter for Research in Immunology and Dermatology, Dermatological Institute of Jalisco, Guadalajara, Jalisco 45190, Mexico ; Department of Physiology, University Center of Health Sciences, University of Guadalajara, Guadalajara, Jalisco 44100, Mexico.
Roberto Arenas-GuzmanMycology Section, General Hospital Dr Manuel Gea Gonzalez, Mexico City 14000, Mexico.
Sergio Estrada-ParraDepartment of Immunology, National School of Biological Sciences, National Polytechnic Institute, Mexico City 11340, Mexico.
Iris Estrada-GarciaDepartment of Immunology, National School of Biological Sciences, National Polytechnic Institute, Mexico City 11340, Mexico.
Julio GranadosDepartment of Transplantation, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City 14000, Mexico.
Instituto Politécnico Nacional · MXAutonomous University of Sinaloa · MXHospital General Dr. Manuel Gea Gonzalez · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXNational Institute of Genomic Medicine · MXTecnológico Nacional de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the introduction of multidrug therapy and the overall reduction of leprosy prevalence in Mexico, the disease remains endemic in certain regions of the country. A genetic basis for the immune susceptibility to

Indexed as

HLA-DRB1leprosypolymorphism

Identifiers

PMID24649058
PMCPMC3917101
OpenAlexW2048739055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.